Infectious Diseases News and Research

RSS

Searching online for diagnosis before visiting doctor can predict dengue fever outbreaks in China

Queensland University of Technology researchers have found the habit of Googling for an online diagnosis before visiting the doctor can be a powerful predictor of infectious diseases outbreaks.

13 Nov 2014

Prescription opioids involved in 67.8% of nationwide ED visits in 2010, find researchers

Researchers from Rhode Island and The Miriam hospitals and the Stanford University School of Medicine have found that prescription opioids, including methadone, were involved in 67.8 percent of (or over 135,971 visits to) nationwide emergency department (ED) visits in 2010, with the highest proportion of opioid overdoses occurring in the South.

12 Nov 2014

Research opens new potential target against enterics

In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.

12 Nov 2014

Successful treatments help HIV-infected persons achieve similar longevity as those without HIV

New research from the Johns Hopkins Bloomberg School of Public Health suggests that HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.

11 Nov 2014

UW SMPH awarded $70 million grant to continue work on Inner-City Asthma Consortium

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded the University of Wisconsin School of Medicine and Public Health a seven-year, $70 million grant for its continuing work on the Inner-City Asthma Consortium (ICAC) -- a nationwide clinical research network to evaluate and develop promising new immune-based treatments.

11 Nov 2014

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

A national survey from Rite Aid and National Foundation for Infectious Diseases reveals that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases.

11 Nov 2014

Child-mortality gap narrows between the poorest and wealthiest families in developing countries

The child-mortality gap has narrowed between the poorest and wealthiest households in a majority of more than 50 developing countries, a new study from the Stanford University School of Medicine has found.

11 Nov 2014

Inovio Pharmaceuticals reports Q3 2014 financial results, provides corporate update

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.

10 Nov 2014

Johnson & Johnson completes acquisition of Alios BioPharma

Johnson & Johnson today announced the completion of the acquisition of Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for a total purchase price of approximately $1.75 billion in cash.

8 Nov 2014

Salk Institute researchers heal injured hearts of living mice

Researchers at the Salk Institute have healed injured hearts of living mice by reactivating long dormant molecular machinery found in the animals' cells, a finding that could help pave the way to new therapies for heart disorders in humans.

7 Nov 2014

Greenwich Hospital partners with ONSF to conduct research on surgical site infections

Research on surgical site infections conducted at Greenwich Hospital in alliance with the ONS Foundation for Clinical Research and Education examined why a certain bacteria is so common in post-surgical shoulder infections and are helping to develop tactics to control it.

7 Nov 2014

EKF Molecular Diagnostics to present at AMP annual meeting

EKF, announces that senior executives from EKF Molecular Diagnostics including CEO, Andrew Webb, will be present at the Association for Molecular Pathology.

From EKF Diagnostics 6 Nov 2014

Study highlights connections between climate change and new outbreak of diseases

Climate change may affect human health directly or indirectly. In addition to increased threats of storms, flooding, droughts, and heat waves, other health risks are being identified. In particular, new diseases are appearing, caused by infectious agents (viruses, bacteria, parasites) heretofore unknown or that are changing, especially under the effect of changes in the climate (change of host, vector, pathogenicity, or strain).

6 Nov 2014

Study: Preclinical oncology course may increase number of students entering the field

With the world facing a shortage of oncologists, Ben-Gurion University of the Negev researchers have determined that preclinical study of oncology may increase the number of students entering the field and may make them more empathetic and concerned about ethical issues of treatment.

6 Nov 2014

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Los Angeles Biomedical Research Institute announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.

6 Nov 2014

Precision awarded $28 million contract to provide management of disease-study specimens for NIAID

Precision for Medicine announced today that its subsidiary, Precision Bioservices, Inc., has been awarded a 7-year contract of up to $28 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases.

4 Nov 2014

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.

4 Nov 2014

FDA approves Fluzone High-Dose vaccine sBLA to include efficacy data in Prescribing Information

Sanofi Pasteur, the vaccines division of Sanofi, today announced that the U.S. Food and Drug Administration has approved the supplemental biologics license application (sBLA) for Fluzone High-Dose (Influenza Vaccine) to include efficacy data in the Prescribing Information.

3 Nov 2014

Infectious Diseases News and Research

Searching online for diagnosis before visiting doctor can predict dengue fever outbreaks in China

Prescription opioids involved in 67.8% of nationwide ED visits in 2010, find researchers

Research opens new potential target against enterics

Successful treatments help HIV-infected persons achieve similar longevity as those without HIV

UW SMPH awarded $70 million grant to continue work on Inner-City Asthma Consortium

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

Child-mortality gap narrows between the poorest and wealthiest families in developing countries

Inovio Pharmaceuticals reports Q3 2014 financial results, provides corporate update

Johnson & Johnson completes acquisition of Alios BioPharma

Salk Institute researchers heal injured hearts of living mice

Greenwich Hospital partners with ONSF to conduct research on surgical site infections

EKF Molecular Diagnostics to present at AMP annual meeting

Study highlights connections between climate change and new outbreak of diseases

Study: Preclinical oncology course may increase number of students entering the field

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Precision awarded $28 million contract to provide management of disease-study specimens for NIAID

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

FDA approves Fluzone High-Dose vaccine sBLA to include efficacy data in Prescribing Information

eBook: Advancing infectious disease vaccine development eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News